NCT02578030View on ClinicalTrials.gov

Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 24, 2015

Primary Completion Date

November 10, 2015

Study Completion Date

November 10, 2015

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

SHP465 12.5mg

DRUG

SHP465 25mg

Trial Locations (3)

33143

QPS MRA, Miami

77098

Houston Clinical Research, Houston

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT02578030 - Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD | Biotech Hunter | Biotech Hunter